The Centers for Medicare & Medicaid Services should determine the extent to which state Medicaid programs comply with federal requirements to cover medication-assisted treatment in all formats, and take actions as appropriate to ensure compliance, the Government Accountability Office said in a report released today. Congress asked GAO to review access barriers to MAT medications. GAO found that some state policies, such as prior authorization requirements and mandated distribution methods, can restrict Medicaid beneficiaries' access to MAT. 

Related News Articles

Headline
The Trump administration announced a trade agreement with the U.K. Dec. 1 on pharmaceuticals that exempts U.K. drug products from Section 232 tariffs. In…
Headline
The AHA, the Maine Hospital Association and four safety-net health systems from across the country Dec. 1 filed a lawsuit in the U.S. District…
Headline
The Centers for Medicare & Medicaid Services Nov. 25 announced lower prices for 15 Medicare Part D drugs selected for the second cycle of negotiations…
Headline
The Advanced Research Projects Agency for Health announced Nov. 21 that it will fund up to $100 million in projects for quantitative measures of mental and…
Headline
Dan Peterson, CEO of behavioral health services at Sutter Health, and Matthew White, M.D., chair of the behavioral health service line at Sutter Health, share…
Headline
The Centers for Medicare & Medicaid Services released a bulletin Nov. 18 summarizing provisions from the budget reconciliation bill related to Medicaid and…